Alternatived Products of [ 28710-97-6 ]
Product Details of [ 28710-97-6 ] CAS No. : 28710-97-6 MDL No. : MFCD00236014 Formula :
C9 H9 N3 O
Boiling Point : - Linear Structure Formula : - InChI Key : - M.W :
175.19
Pubchem ID : - Synonyms :
Calculated chemistry of [ 28710-97-6 ] Expand+ Physicochemical Properties Num. heavy atoms : 13 Num. arom. heavy atoms : 11 Fraction Csp3 : 0.0 Num. rotatable bonds : 1 Num. H-bond acceptors : 1.0 Num. H-bond donors : 2.0 Molar Refractivity : 50.79 TPSA : 63.81 Ų
Pharmacokinetics GI absorption : High BBB permeant : No P-gp substrate : No CYP1A2 inhibitor : Yes CYP2C19 inhibitor : No CYP2C9 inhibitor : No CYP2D6 inhibitor : No CYP3A4 inhibitor : No Log Kp (skin permeation) : -6.66 cm/s
Lipophilicity Log Po/w (iLOGP) : 1.42 Log Po/w (XLOGP3) : 1.0 Log Po/w (WLOGP) : 0.76 Log Po/w (MLOGP) : 1.4 Log Po/w (SILICOS-IT) : 0.92 Consensus Log Po/w : 1.1
Druglikeness Lipinski : 0.0 Ghose : None Veber : 0.0 Egan : 0.0 Muegge : 1.0 Bioavailability Score : 0.55
Water Solubility Log S (ESOL) : -2.12 Solubility : 1.34 mg/ml ; 0.00765 mol/l Class : Soluble Log S (Ali) : -1.93 Solubility : 2.06 mg/ml ; 0.0118 mol/l Class : Very soluble Log S (SILICOS-IT) : -2.47 Solubility : 0.591 mg/ml ; 0.00337 mol/l Class : Soluble
Medicinal Chemistry PAINS : 0.0 alert Brenk : 0.0 alert Leadlikeness : 1.0 Synthetic accessibility : 1.88
Safety of [ 28710-97-6 ] Signal Word: Warning Class: N/A Precautionary Statements: P280 UN#: N/A Hazard Statements: H302-H312-H332 Packing Group: N/A GHS Pictogram:
Application In Synthesis of [ 28710-97-6 ] * All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 28710-97-6 ]
1 [ 123-91-1 ] [ 28710-97-6 ] [ 75-36-5 ] [ 52473-01-5 ] 2 [ 674-82-8 ] [ 28710-97-6 ] 5-methyl-1-phenyl-4<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrimidine-2,7-dione [ No CAS ] 3 [ 75-44-5 ] [ 28710-97-6 ] <i>N</i>,<i>N</i>'-bis-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)-urea [ No CAS ] 4 [ 112-16-3 ] [ 28710-97-6 ] 5-dodecanoylamino-2-phenyl-1,2-dihydro-pyrazol-3-one [ No CAS ] 5 [ 28710-97-6 ] [ 110-62-3 ] [ 102321-93-7 ] 6 [ 28710-97-6 ] [ 10553-78-3 ] acetylmercapto-acetic acid-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-ylamide) [ No CAS ] 7 [ 28710-97-6 ] [ 36854-57-6 ] 2-phenyl-butyric acid-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-ylamide) [ No CAS ] 8 [ 28710-97-6 ] <i>N</i>-(1,3-diethyl-2,4,6-trioxo-tetrahydro-pyrimidin-5-ylidenemethyl)-acetanilide [ No CAS ] 1,3-diethyl-5-(5-amino-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-ylmethylene)-barbituric acid [ No CAS ] 9 [ 28710-97-6 ] [ 854166-18-0 ] 3-nitro-4-octadecyloxy-benzoic acid-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-ylamide) [ No CAS ] 10 [ 28710-97-6 ] [ 333-20-0 ] (5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)-thiourea [ No CAS ] 11 [ 28710-97-6 ] [ 100-34-5 ] [ 53627-79-5 ] 12 [ 28710-97-6 ] [ 541-41-3 ] (5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)-carbamic acid ethyl ester [ No CAS ] 13 [ 28710-97-6 ] [ 108-24-7 ] [ 52472-96-5 ] 14 [ 28710-97-6 ] [ 141-97-9 ] 5-methyl-1-phenyl-4<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrimidine-2,7-dione [ No CAS ] 15 [ 28710-97-6 ] [ 622-59-3 ] 5-(6-methyl-benzothiazol-2-ylamino)-2-phenyl-1,2-dihydro-pyrazol-3-one [ No CAS ] 16 [ 28710-97-6 ] [ 100-52-7 ] [ 101117-50-4 ] 17 [ 28710-97-6 ] [ 100-52-7 ] [ 103267-13-6 ] 18 [ 28710-97-6 ] [ 106-49-0 ] 5-(4-methyl-anilino)-2-phenyl-1,2-dihydro-pyrazol-3-one [ No CAS ] 19 [ 28710-97-6 ] [ 98-88-4 ] [ 52473-03-7 ] Reference: [1]Nippon Shashin Gakkaishi,1951,vol. 14,p. 37,42
Chem.Abstr.,1953,p. 3155 [2]Journal of the American Chemical Society,1942,vol. 64,p. 2133,2134 20 [ 28710-97-6 ] [ 103-71-9 ] <i>N</i>-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)-<i>N</i>'-phenyl-urea [ No CAS ] 21 [ 28710-97-6 ] [ 103-72-0 ] 1-(5-oxo-1-phenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)-3-phenyl-thiourea [ No CAS ]